The Effectiveness of Modern Antihistamines for Treatment of Allergic Rhinitis – An IPD Meta-Analysis of 140,853 Patients doi:10.2332/allergolint.12-OA-0486 Background: Allergic rhinitis represents a worldwide health problem. The prevalence is increasing. The aim of this study was to analyse the correlation between the severity of allergic rhinitis and an adequate treatment dose of modern oral antihistamines. Methods: From a comprehensive databank containing data from ten different open-label prospective observational studies including raw data of 140,853 patients with allergic rhinitis, symptomatology variables were analysed and scored to study the effects of treatment with four antihistamines (Desloratadine, Ebastine, Fexofenadine, Levocetirizine) alone or in combination with intranasal corticosteroids. The patient data were collected in 23,606 study centres from Germany, mostly medical specialist and some primary care physicians in private practice. The analyses were performed via individual patient data meta-analysis techniques. Results: Finally 92,900 patient data from nine of ten studies could be analysed. One study with data of 47,953 patients was excluded due to incomplete treatment documentation. Both monotherapy analysis subgroups (Total Symptom Score and Total Nasal Symptom Score) were significantly better than those of their combinations with intranasal steroids. Monotherapy with levocetirizine was determined to be significantly more effective in lowering the Total Symptom Score (p < 0.001) and the Total Nasal Symptom Score (p < 0.05) than the other antihistamines. In the next stage, a greater positive effect of levocetirizine was demonstrated in relation to the severity of the clinical symptoms of allergic rhinitis (Total Nasal Symptom Score in cases with severe symptomatology [effect size = -0.09]). Conclusions: Levocetirizine asserted itself as the only antihistamine compared with the others as significant in this analysis. The study authors recommend monotherapy with the new-generation antihistamine levocetirizine, especially in severe cases of allergic rhinitis. KEY WORDS: allergic rhinitis, Desloratadine, Ebastine, Fexofenadine, Levocetirizine, treatment ABBREVIATIONS: TNSS, Total Nasal Symptom Score; TOSS,Total Ocular Symptom Score; TSS, Total Symptom Score; IPD, Individual Patient Data. Received: 30 July 2012. Accepted: 28 November 2012. Allergology International : In Press |
Friday, September 27, 2013
0 The Effectiveness of Modern Antihistamines for Treatment of Allergic Rhinitis
Thursday, September 26, 2013
0 Recent advances in diagnosis and therapy of allergic rhinitis and asthma in childhood
Recent advances in diagnosis and therapy of allergic rhinitis and asthma in childhood
Abstract
Keywords
Full Text:Â PDFÂ
Monday, September 23, 2013
0 Control of Allergic Rhinitis and Asthma Test (CARAT): dissemination and applications in primary care
| Discussion Paper |
Control of Allergic Rhinitis and Asthma Test (CARAT): dissemination and applications in primary care
Pedro Azevedo1, Jaime Correia de Sousa2, Jean Bousquet3, António Bugalho-Almeida4, Stefano R Del Giacco5, Pascal Demoly6, Tari Haahtela7, Tiago Jacinto8, Vanessa Garcia-Larsen9, Thys van der Molen10, Mário Morais-Almeida11, Luis Nogueira-Silva12, Ana M Pereira13, Miguel Román RodrÃguez14, Bárbara G Silva15, Ioanna G Tsiligianni16, Hakan Yaman17, Barbara Yawn18, *João A Fonseca19, in collaboration with the WHO Collaborative Center for Asthma and Rhinitis, Montpellier
Abstract
Asthma frequently occurs in association with allergic rhinitis and a combined management approach has been suggested. The Control of Allergic Rhinitis and Asthma Test (CARAT) is the first questionnaire to assess control of both diseases concurrently. However, to have an impact on healthcare it needs to be disseminated and adopted. In this paper we discuss the dissemination of CARAT in different countries and its possible applications in primary care. At present, the adaptation of CARAT for use in different languages and cultures is being led by volunteer researchers and clinicians in 15 countries. Website and smartphone applications have been developed, and a free open model of distribution was adopted to contribute to the dissemination of CARAT. Examples of dissemination activities include distribution of leaflets and posters, educational sessions on the use of the questionnaire in the follow-up of patients, development of clinical studies, collaborations with professional organisations and health authorities, and the inclusion of CARAT in clinical guidelines. The adoption of innovations is an important challenge in healthcare today, and research on the degree of success of dissemination strategies using suitable methods and metrics is much needed. We propose that CARAT can be used in a range of settings and circumstances in primary care for clinical, research and audit purposes, within the overall aim of increasing awareness of the level of disease control and strengthening the partnership between patients and doctors in the management of asthma and rhinitis.Â
Cite as: Azevedo P, Correia de Sousa J, Bousquet J, Bugalho-Almeida A, Del Giacco SR, Demoly P, Haahtela T, Jacinto T, Garcia-Larsen V, van der Molen T, Morais-Almeida M, Nogueira-Silva L, Pereira AM, RodrÃguez MR, Silva BG, Tsiligianni IG, Yaman H, Yawn B, Fonseca JA, in collaboration with the WHO Collaborative Center for Asthma and Rhinitis, Montpellier. Control of Allergic Rhinitis and Asthma Test (CARAT): dissemination and applications in primary care. Prim Care Respir J 2013; Available from: URL: http://dx.doi.org/10.4104/pcrj.2013.00012
Keywords
Asthma, rhinitis, control, questionnaire, dissemination, cultural adaptation
* Corresponding author. João A Fonseca Tel: +351914767661 Fax: +351914767661 Email:fonseca.ja@gmail.com
| View full text as PDF document | |
| Right click on this DOI link and copy link/shortcut to cite this article (What is a DOI link?) | |
Export to bibliographic software or plain text | |
Post to CiteULike | |
Email this article to friend/s or colleague/s |
Original Article | |||||||||||||||||||||||||||||||
| |||||||||||||||||||||||||||||||
Educational & Teaching Material | |||||||||||||||||||||||||
| |||||||||||||||||||||||||
Editorial | |||||||||||||||||||||||||||
| |||||||||||||||||||||||||||
Sputum mediator profiling and relationship to airway wall geometry imaging in severe asthma
Published: 11 February 2013
Abstract (provisional)
Background
Methods
Results
Conclusions
The complete article is available as a provisional PDF. The fully formatted PDF and HTML versions are in production. |
Services on Demand
Article
pdf in English
Article in xml format
Article references
How to cite this article
Curriculum ScienTI
Automatic translation
Indicators
Related links
Bookmark
- Share on deliciousShare on googleShare on twitterShare on diggShare on citeulikeShare on connotea|More Sharing ServicesMore
Sao Paulo Medical Journal
Print version ISSN 1516-3180
Sao Paulo Med. J. vol.130 no.5 São Paulo  2012
http://dx.doi.org/10.1590/S1516-31802012000500005Â
IIMD, PhD. Professor of Dermatology, Department of Dermatology and Radiotherapy, Botucatu Medical School, Universidade Estadual Paulista (Unesp), Botucatu, São Paulo, Brazil
IIIMD, PhD. Professor of Endocrinology and Metabology, Department of Internal Medicine, Botucatu Medical School, Universidade Estadual Paulista (Unesp), Botucatu, São Paulo, Brazil
IVMD, PhD. Professor of Endocrinology and Metabology, Internal Medicine Department, Botucatu Medical School, Universidade Estadual Paulista (Unesp), Botucatu, São Paulo, Brazil
DESIGN AND SETTING:Â Case-control study including 115 patients with CIU at a tertiary public institution.
METHODS:Â The patients were evaluated with regard to occurrence of angioedema and presence of ATD, hypothyroidism or hyperthyroidism.
RESULTS:Â Angioedema was detected in 70 patients (60.9%). There were 22 cases (19.1%) of ATD, 19 (16.5%) of hypothyroidism and nine (7.8%) of hyperthyroidism. The risk among patients with ATD was 16.2 times greater than among those without this thyroid abnormality (confidence interval, CI = 2.07-126.86). The odds ratio for hypothyroidism was 4.6 (CI = 1.00-21.54) and, for hyperthyroidism, 3.3 (CI = 0.38-28.36).
CONCLUSIONS:Â Patients with CIU and ATD presented greater risk of angioedema, which reinforces the idea that a relationship exists between this allergic condition and thyroid autoimmunity. This finding could imply that such patients require specifically directed therapy.
TIPO DE ESTUDO E LOCAL: Estudo caso-controle, incluindo 115 pacientes com UCI em uma instituição pública terciária.
MÃTODOS: Os pacientes foram avaliados quanto à ocorrência de angioedema e à presença de DAT, hiper ou hipotireoidismo.
RESULTADOS: Angioedema ocorreu em 70 pacientes (60,9%). Foram observados 22 (19,1%) casos de DAT, 19 (16,5%) de hipotireoidismo e 9 (7,8%) de hipertireoidismo. Os pacientes com DAT apresentaram risco 16,2 vezes maior de angioedema do que os sem a alteração tireoidiana (intervalo de confiança, IC = 2.07-126.86). Oodds ratio, para hipotireoidismo, foi de 4,6 (IC = 1.00-21.54) e para hipertireoidismo foi de 3,3 (IC = 0.38-28.36).
CONCLUSÃES: Pacientes com UCI e DAT apresentaram maior risco de angioedema, reforçando a ideia de existência de relação entre o quadro alérgico e autoimunidade tireoidiana. Este achado poderia implicar em um direcionamento terapêutico especÃfico para tais pacientes.
